Robert Ezzell

Robert Ezzell is an accomplished Regulatory Affairs professional with expertise in drug, biologics, and combination product regulations and submissions. They served as Head of Regulatory Affairs at Glympse Bio, developing strategies for innovative drug delivery systems and leading successful FDA submissions for clinical studies. Ezzell has also contributed to academia as a Graduate Instructor at Northeastern University, teaching various regulatory affairs courses. Currently, they hold the position of Director of Regulatory Operations at Avance Clinical, continuing to leverage their extensive knowledge of regulatory requirements and compliance. Ezzell's educational background includes a PhD in Cell & Molecular Biology from the University of California, Berkeley, and an MBA in Operations & Finance from Northeastern University.